You are here

Medical Testing

Both Paxlovid, molnupiravir lower COVID Omicron deaths, hospitalizations -- studies

Two new studies describe the benefits of the antiviral drugs nirmatrelvir-ritonavir (Paxlovid) and molnupiravir in reducing SARS-CoV-2 Omicron hospitalizations and death, with one finding that the former is more effective than the latter at lowering death rates.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

UK reports nursing home COVID outbreak; U.S. shows slow but steady increase

In a technical briefing on SARS-CoV-2 variants today, the UK Health Security Agency (HSA) revealed that, of 34 confirmed involving the highly mutated BA.2.86 variant, 28 were from a single outbreak at a nursing home, an early sign that it can spread in close-contact settings.

Problem, Solution, SitRep, or ?: 

U.S. and Canada: Cancer diagnoses fell early in COVID pandemic, but many types eventually climbed again

A pair of new studies documents initial drops—and, in some cases, rebounds—in cancer diagnoses in Canada and the United States in the first year of the COVID-19 pandemic.

...

 

 

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Blood cots may explain brain fog and fatigue among COVID victims--study

Study links blood clots to brain fog after Covid

A recent UK study suggests that blood clots in the brain or lungs may explain some of the common symptoms experienced by people with "long Covid", including brain fog and fatigue. The study, which included 1,837 people admitted to hospital due to Covid, found that two blood proteins, fibrinogen and D-dimer, were associated with cognitive problems. It is estimated that 16% of these patients experience difficulties with thinking, concentrating, or remembering for at least six months.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Medical Testing
howdy folks
Page loaded in 0.594 seconds.